Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s Potential Black Hole: House Investigates Departure Of Acting Head Of Medical Products Office

This article was originally published in The Pink Sheet Daily

Executive Summary

Energy and Commerce Committee letter states public information discrepancies raised questions about Leona Brenner-Gati’s status and “the circumstances surrounding her resignation.”


Related Content

Moscicki, One Of US FDA's Industry Connections, Moves To PhRMA
Learning To Drive The ‘Chariot’: FDA Deputy Califf’s New Role
FDA’s Autor Moves To Mylan: Company’s Gain May Also Be Company’s Loss
FDA Leadership Challenge: Temporary Medical Products Office Head Departs; Replacement Unknown
FDA Generics Director’s Departure Shows Why Chemistry Matters
CDER Taps Genzyme Exec As Deputy Director For Science Operations
Spielberg’s Replacement At FDA Also Will Have Strong Industry Ties
FDA's Spielberg To Focus On Cross-Center Collaboration, Hamburg Says
FDA Reorganization Adds "Directorate" Layer, But Sharpens Agency's Focus
FDA Reorganization Creates Prominent Roles For Mercy Hospital's Spielberg, CDER's Autor


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts